Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

The carotenoid fucoxanthin can sensitize multidrug resistant cancer cells to doxorubicin via induction of apoptosis, inhibition of multidrug resistance proteins and metabolic enzymes
Safaa Yehia Eid, Mohammad Althubiti, Mohamed E. Abdallah, et al.
Phytomedicine (2020) Vol. 77, pp. 153280-153280
Closed Access | Times Cited: 45

Showing 1-25 of 45 citing articles:

Targeting Drug Chemo-Resistance in Cancer Using Natural Products
Wamidh H. Talib, Ahmad R. Alsayed, Muna Barakat, et al.
Biomedicines (2021) Vol. 9, Iss. 10, pp. 1353-1353
Open Access | Times Cited: 139
The Antitumour Mechanisms of Carotenoids: A Comprehensive Review
Andrés Baeza-Morales, Miguel Medina-García, Pascual Martínez-Peinado, et al.
Antioxidants (2024) Vol. 13, Iss. 9, pp. 1060-1060
Open Access | Times Cited: 10
Phytochemicals in Gynecological Cancer Prevention
Marta Woźniak, Rafał Krajewski, Sebastian Makuch, et al.
International Journal of Molecular Sciences (2021) Vol. 22, Iss. 3, pp. 1219-1219
Open Access | Times Cited: 44
Isorhamnetin induces cell cycle arrest and apoptosis by triggering DNA damage and regulating the AMPK/mTOR/p70S6K signaling pathway in doxorubicin-resistant breast cancer
Tianshu Yang, Yi Xiao, Shuo Liu, et al.
Phytomedicine (2023) Vol. 114, pp. 154780-154780
Closed Access | Times Cited: 19
Doxorubicin-sanguinarine nanoparticles: formulation and evaluation of breast cancer cell apoptosis and cell cycle
Mahmoud Zaki El-Readi, Majed Abdurhman Abdulkarim, Ahmed A. H. Abdellatif, et al.
Drug Development and Industrial Pharmacy (2024), pp. 1-15
Closed Access | Times Cited: 8
A Narrative Review of the Role of Diet and Lifestyle Factors in the Development and Prevention of Endometrial Cancer
Hajar Ku Yasin, Anthony H. Taylor, Thangesweran Ayakannu
Cancers (2021) Vol. 13, Iss. 9, pp. 2149-2149
Open Access | Times Cited: 41
An Updated Comprehensive Review on Vitamin A and Carotenoids in Breast Cancer: Mechanisms, Genetics, Assessment, Current Evidence, and Future Clinical Implications
Jee Ah Kim, Ja‐Hyun Jang, Soo‐Youn Lee
Nutrients (2021) Vol. 13, Iss. 9, pp. 3162-3162
Open Access | Times Cited: 40
Multiple Molecular Mechanisms to Overcome Multidrug Resistance in Cancer by Natural Secondary Metabolites
Mahmoud Zaki El-Readi, Ahmed M. Al‐Abd, Mohammad Althubiti, et al.
Frontiers in Pharmacology (2021) Vol. 12
Open Access | Times Cited: 34
Multidrug Resistance in Cancer Cells: Focus on a Possible Strategy Plan to Address Colon Carcinoma Cells
Chenmala Karthika, R. Sureshkumar, Mehrukh Zehravi, et al.
Life (2022) Vol. 12, Iss. 6, pp. 811-811
Open Access | Times Cited: 24
Fabrication of starch/zein-based microcapsules for encapsulation and delivery of fucoxanthin
Yuying Zhao, Jinglei Zhi, Shuyao Huang, et al.
Food Chemistry (2022) Vol. 392, pp. 133282-133282
Closed Access | Times Cited: 23
Fucoxanthin Is a Potential Therapeutic Agent for the Treatment of Breast Cancer
Tsz-Ying Lau, Hiu Yee Kwan
Marine Drugs (2022) Vol. 20, Iss. 6, pp. 370-370
Open Access | Times Cited: 23
Haloarchaeal carotenoids exert an in vitro antiproliferative effect on human breast cancer cell lines
Micaela Giani, Yoel Genaro Montoyo-Pujol, Gloria Peiró, et al.
Scientific Reports (2023) Vol. 13, Iss. 1
Open Access | Times Cited: 16
Discovery of new pyrimidopyrrolizine/indolizine-based derivatives as P-glycoprotein inhibitors: Design, synthesis, cytotoxicity, and MDR reversal activities
Ahmed M. Shawky, Ashraf N. Abdalla, Nashwa A. Ibrahim, et al.
European Journal of Medicinal Chemistry (2021) Vol. 218, pp. 113403-113403
Closed Access | Times Cited: 30
Chemosensitization of HT29 and HT29-5FU Cell Lines by a Combination of a Multi-Tyrosine Kinase Inhibitor and 5FU Downregulates ABCC1 and Inhibits PIK3CA in Light of Their Importance in Saudi Colorectal Cancer
Ashraf N. Abdalla, Waleed H. Malki, Amal Qattan, et al.
Molecules (2021) Vol. 26, Iss. 2, pp. 334-334
Open Access | Times Cited: 24
Protective Effects of Oral Pharmaceutical Solution of Fucoxanthin Against Paracetamol-Induced Liver Injury: Modulation of Drug-Metabolizing Enzymes, Oxidative Stress, and Apoptotic Pathways in Rats
Safaa Yehia Eid, Maimonah Fuad Koshak, Mohamed E. Elzubier, et al.
Drug Development and Industrial Pharmacy (2025), pp. 1-16
Closed Access
Fucoxanthin from Laminaria japonica Targeting PANoptosis and Ferroptosis Pathways: Insights into Its Therapeutic Potential Against Ovarian Cancer
Yaze Wang, Yimin Mao, Hui Liu, et al.
Marine Drugs (2025) Vol. 23, Iss. 3, pp. 123-123
Open Access
Dual-modulation of nutrient-transporter axis and functionalized carriers: A paradigm shift for precision oral vitamin D delivery
Zixiao Wang, Yixiang Liu
Colloids and Surfaces B Biointerfaces (2025) Vol. 253, pp. 114769-114769
Closed Access
Cytotoxicity of Seaweed Compounds, Alone or Combined to Reference Drugs, against Breast Cell Lines Cultured in 2D and 3D
Fernanda Malhão, Alice A. Ramos, Ana Catarina Macedo, et al.
Toxics (2021) Vol. 9, Iss. 2, pp. 24-24
Open Access | Times Cited: 22
Antioxidative and Anti-Inflammatory Protective Effects of Fucoxanthin against Paracetamol-Induced Hepatotoxicity in Rats
Maimonah Fuad Koshak, Mahmoud Zaki El-Readi, Mohamed E. Elzubier, et al.
Marine Drugs (2023) Vol. 21, Iss. 11, pp. 592-592
Open Access | Times Cited: 9
ATP-Binding Cassette Subfamily G Member 2 in Acute Myeloid Leukemia: A New Molecular Target?
Daniela Damiani, Mario Tiribelli
Biomedicines (2024) Vol. 12, Iss. 1, pp. 111-111
Open Access | Times Cited: 3
Fucoxanthin: From chemical properties and sources to novel anticancer mechanistic insights and synergistic therapeutic opportunities
Wojciech Koch, Wirginia Kukuła‐Koch, Anna Wawruszak, et al.
Current Research in Biotechnology (2024) Vol. 7, pp. 100203-100203
Open Access | Times Cited: 3
Dietary carotenoid fucoxanthin as a promising biomarker to target the cancer cells: A focused review
A. Vijayalakshmi, T. Prabha, V. Lalitha, et al.
Annals of Phytomedicine An International Journal (2022) Vol. 11, Iss. 1
Open Access | Times Cited: 13
Fucoxanthin suppresses the malignant progression of ovarian cancer by inactivating STAT3/c-Myc signaling.
Zhan Zhang, Youqun Wang, Jianhua Li
PubMed (2023) Vol. 15, Iss. 4, pp. 2528-2540
Closed Access | Times Cited: 8
Barleria prionitis L. extracts ameliorate doxorubicin-induced acute kidney injury via modulation of oxidative stress, inflammation, and apoptosis
Sachinthi S. Amarasiri, Anoja Priyadarshani Attanayake, L.D.A.M. Arawwawala, et al.
Journal of Traditional and Complementary Medicine (2023) Vol. 13, Iss. 5, pp. 500-510
Open Access | Times Cited: 8
Strategies to enhance the response of liver cancer to pharmacological treatments
José J.G. Marı́n, Rocı́o I.R. Macı́as, Maitane Asensio, et al.
AJP Cell Physiology (2024) Vol. 327, Iss. 1, pp. C11-C33
Closed Access | Times Cited: 2
Page 1 - Next Page

Scroll to top